E-mail| Contact Us| Volunteer| Make A Gift| En Español| Employees

  • Take Control of your Smoking History
  • World-class cancer care made LG Health his top destination

Learn More

Ann B. Barshinger Cancer Institute

Read the Oncology Program Annual Report 2013
CyberKnife® M6™

CyberKnife® M6

When you’re facing news of a tumor, you and your family want the best treatment options possible. In 2013, the Lancaster General Health Ann B. Barshinger Cancer Institute became the first hospital in the U.S. to offer the CyberKnife® M6™ system. This state-of-the-art, pain-free radiation therapy has been giving new hope to patients with tumors that are either too large or too complex to be removed surgically.

Reduced treatment time, expanded options

Now our treatment capabilities are going even further with an upgrade to our CyberKnife® M6™ System -- the InCise™ Multileaf Collimator. Recognized as the most advanced robotic radiosurgery system available, the collimator reduces treatment time from about 40 to 20 minutes, and can treat larger and more complex tumors, greatly expanding the number of patients eligible for CyberKnife technology.

Intense accuracy

The collimator’s individual leaves can move independently to shape the radiation beam to the complex geometry of the tumors.  High doses of radiation are delivered with extreme accuracy. CyberKnife’s ability to manage motion in real time helps ensure that radiation is delivered only to the tumor, while sparing healthy tissue. This is particularly helpful for treating tumors of the lung, liver, and prostate, where movement is common.

The CyberKnife® M6™ system treats cancerous and non-cancerous tumors anywhere in the body, including: head and neck, spine, liver, pancreas, prostate, lung, and other soft tissues.

Advanced technology, many advantages

The CyberKnife® M6™ System can be used when surgery is not appropriate or desirable. Compared to traditional radiation treatments, the CyberKnife uses a smaller radiation field that pinpoints the tumor, sparing healthy tissue. Other advantages include:

  • No incisions
  • No pain
  • No anesthesia
  • No hospitalization requirement
  • Reduced radiation exposure to healthy tissue
  • Flexibility to treat large and/or complex tumors
  • Shorter course of therapy
  • Fewer short- and long-term side effects
  • Little or no recovery time
  • Immediate return to daily activities

What to expect

  • First, you’ll be evaluated by the CyberKnife treatment team, including a radiation oncologist.
  • In some cases, your team may recommend placing small, gold fiducial markers to help identify the exact location of the tumor during treatment.
  • A technician takes an MRI, CT and/or CT/PET scan to determine the size, shape and location of the tumor. The radiation oncologist uses this information to develop a specific treatment plan.
  • During treatment, you are comfortably positioned on the treatment table. CyberKnife delivers radiation, while taking continual X-ray images to track and correct for any movement of the tumor. Most patients receive from one to five treatments. 

For more information about CyberKnife, speak to your oncology specialist.

LG Health’s Ann B. Barshinger Cancer Institute is the only provider in Central Pennsylvania to offer all four types of radiosurgery: Gamma Knife®, TomoTherapy®, CyberKnife® M6 and TrueBeam™ technology through an integrated-care approach.

Find A Doctor
Advanced Search
Call 1-888-LGH-INFO

Learn More


Contact Us:

1-888-LGH-INFO (544-4636) Have a question?
Follow us online.